• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Liquid oral magnetic particles as a gastrointestinal contrast agent for MR imaging: efficacy in vivo.

作者信息

Rubin D L, Muller H H, Sidhu M K, Young S W, Hunke W A, Gorman W G

机构信息

Department of Diagnostic Radiology, Stanford University School of Medicine, CA 94305.

出版信息

J Magn Reson Imaging. 1993 Jan-Feb;3(1):113-8. doi: 10.1002/jmri.1880030119.

DOI:10.1002/jmri.1880030119
PMID:8428076
Abstract

Recent in vitro studies suggested there is an optimal range of concentration and viscosity for a liquid formulation of oral magnetic particles (WIN 39996) for magnetic resonance (MR) imaging of the gastrointestinal (GI) tract. To determine whether this formulation is also effective in vivo and whether differing viscosity and administration regimen affect GI distribution of the contrast agent, a range of concentrations of iron (75, 150, and 200 micrograms/mL) and viscosities (1, 150, and 600 cp) were imaged in dogs at 1.5 T with conventional spin-echo and fat-saturation pulse sequences. The effects of dose regimen (single vs divided dose) and subject position (supine vs right lateral decubitus) were also studied. The 75 and 200 micrograms/mL concentrations were unacceptable for MR imaging, while 150 micrograms/mL was effective. The GI distribution of the contrast agent was affected jointly by viscosity, subject position, and dose regimen. The 150 micrograms/mL formulation produced excellent GI contrast enhancement in vivo for both 150- and 600-cp viscosities. The choice of optimal viscosity may depend on the preferred administration regimen.

摘要

相似文献

1
Liquid oral magnetic particles as a gastrointestinal contrast agent for MR imaging: efficacy in vivo.
J Magn Reson Imaging. 1993 Jan-Feb;3(1):113-8. doi: 10.1002/jmri.1880030119.
2
Optimization of an oral magnetic particle formulation as a gastrointestinal contrast agent for magnetic resonance imaging.
Invest Radiol. 1994 Jan;29(1):81-6. doi: 10.1097/00004424-199401000-00017.
3
Influence of viscosity on WIN 39996 as a contrast agent for gastrointestinal magnetic resonance imaging.
Invest Radiol. 1995 Apr;30(4):226-31. doi: 10.1097/00004424-199504000-00005.
4
Formulation of radiographically detectable gastrointestinal contrast agents for magnetic resonance imaging: effects of a barium sulfate additive on MR contrast agent effectiveness.用于磁共振成像的可放射检测胃肠道造影剂的配方:硫酸钡添加剂对磁共振造影剂效果的影响。
Magn Reson Med. 1992 Jan;23(1):154-65. doi: 10.1002/mrm.1910230116.
5
Superparamagnetic iron oxide hepatic MR imaging: efficacy and safety using conventional and fast spin-echo pulse sequences.
J Magn Reson Imaging. 1995 Sep-Oct;5(5):566-70. doi: 10.1002/jmri.1880050516.
6
Ferrimagnetic susceptibility contrast agents.亚铁磁性对比剂。
Acta Radiol Suppl. 1993;387:1-30.
7
Magnetic microparticle aggregation for viscosity determination by MR.用于磁共振黏度测定的磁性微粒聚集
Magn Reson Med. 2008 Mar;59(3):515-20. doi: 10.1002/mrm.21526.
8
Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.使用临床3.0特斯拉磁共振扫描仪,通过奥曲肽偶联的超小超顺磁性氧化铁颗粒对乳腺肿瘤进行特异性靶向。
Acta Radiol. 2009 Jul;50(6):583-94. doi: 10.1080/02841850902902557.
9
Use of AMI-227 as an oral MR contrast agent.使用AMI-227作为口服磁共振造影剂。
Magn Reson Imaging. 1994;12(4):631-9. doi: 10.1016/0730-725x(94)92458-9.
10
Contribution of oral magnetic particles in MR imaging of the abdomen with spin-echo and gradient-echo sequences.
J Magn Reson Imaging. 1993 Jan-Feb;3(1):107-12. doi: 10.1002/jmri.1880030118.